Hasija Amit is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $158K.
Profile
Amit Hasija is the Chief Financial Officer and Executive Vice President of Corporate Development at Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on developing cardiovascular treatments. He has been involved in the company's financial and strategic operations, particularly in relation to their lead product, etripamil.
Amit Hasija is the Chief Financial Officer and Executive Vice President of Corporate Development at Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on developing cardiovascular treatments. He has been involved in the company's financial and strategic operations, particularly in relation to their lead product, etripamil.…
Has Hasija Amit been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($158K) across all tracked filings.
Where can I see all of Hasija Amit's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
